Hyperfine, Inc. (HYPR)
0.8133
-0.02
(-2.83%)
USD |
NASDAQ |
Sep 04, 16:00
0.8299
+0.02
(+2.04%)
After-Hours: 20:00
Hyperfine SG&A Expense (TTM) : 26.53M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 26.53M |
| March 31, 2026 | 26.33M |
| December 31, 2025 | 26.39M |
| September 30, 2025 | 26.34M |
| June 30, 2025 | 26.62M |
| March 31, 2025 | 26.93M |
| December 31, 2024 | 26.62M |
| September 30, 2024 | 26.83M |
| June 30, 2024 | 26.97M |
| March 31, 2024 | 28.08M |
| December 31, 2023 | 30.38M |
| September 30, 2023 | 32.39M |
| Date | Value |
|---|---|
| June 30, 2023 | 31.88M |
| March 31, 2023 | 39.83M |
| December 31, 2022 | 46.62M |
| September 30, 2022 | 54.66M |
| June 30, 2022 | 57.64M |
| March 31, 2022 | 50.33M |
| December 31, 2021 | 37.86M |
| September 30, 2021 | 24.23M |
| June 30, 2021 | 14.62M |
| March 31, 2021 | 6.167M |
| December 31, 2020 | 3.113M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Abbott Laboratories | 13.94B |
| AngioDynamics, Inc. | 157.09M |
| Alphatec Holdings, Inc. | 524.06M |
| AtriCure, Inc. | 323.68M |
| Baxter International, Inc. | 2.932B |